Cellectar Biosciences Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLEICHROEDER LP | 05/14/2026 | 100.00 K | $254.00 K | 0.00% | 2.36% |
| 05/15/2026 | 81.88 K | $207.99 K | 100.00% | 1.93% | |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 52.78 K | $134.06 K | 84.31% | 1.24% |
| SEQUOIA FINANCIAL ADVISORS, LLC | 04/30/2026 | 18.85 K | $47.88 K | -25.64% | 0.44% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 16.57 K | $42.10 K | 100.00% | 0.39% |
| WARBERG ASSET MANAGEMENT LLC | 05/07/2026 | 13.90 K | $35.31 K | 0.00% | 0.33% |
| RIVERVIEW CAPITAL ADVISERS, LLC | 05/14/2026 | 10.38 K | $50.05 K | 0.00% | 0.24% |
| UBS GROUP AG | 05/05/2026 | 9.65 K | $24.50 K | 271.32% | 0.23% |
| BLACKROCK, INC. | 05/13/2026 | 4.75 K | $12.05 K | 0.00% | 0.11% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 793 | $2.01 K | -56.74% | 0.02% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 563 | $1.43 K | 100.00% | 0.01% |
| MORGAN STANLEY | 05/15/2026 | 510 | $1.30 K | 0.00% | 0.01% |
| TD WATERHOUSE CANADA INC. | 05/12/2026 | 63 | $154 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 11 | $28 | 0.00% | 0.00% |
| FMR LLC | 05/15/2026 | 10 | $25 | 100.00% | 0.00% |
| US BANCORP \DE\ | 05/15/2026 | 3 | $8 | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 05/15/2026 | 3 | $8 | 0.00% | 0.00% |
| DANSKE BANK A/S | 05/12/2026 | 2 | $5 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 1 | $2 | -85.71% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| DRW SECURITIES, LLC | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Cellectar Biosciences Inc institutional Ownership - FAQ's
During the previous two years, 36 institutional investors and hedge funds held shares of Cellectar Biosciences Inc. The most heavily invested institutionals were:
Bleichroeder LP: 100,000
GEODE CAPITAL MANAGEMENT, LLC: 52,778
Sequoia Financial Advisors, LLC: 18,850
VANGUARD FIDUCIARY TRUST CO: 16,573
Warberg Asset Management LLC: 13,900
Riverview Capital Advisers, LLC: 10,384
7.33% of Cellectar Biosciences Inc stock is owned by institutional investors.
Institutional investors have bought a total of 3.01 M shares in the last 24 months. This purchase volume represents approximately $8.28 M in transactions.